Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · IEX Real-Time Price · USD
1.230
+0.080 (6.96%)
At close: Mar 28, 2024, 4:00 PM
1.270
+0.040 (3.25%)
After-hours: Mar 28, 2024, 7:57 PM EDT

Microbot Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
0000000001.01
Upgrade
Revenue Growth (YoY)
---------487.58%
Upgrade
Gross Profit
0000000001.01
Upgrade
Selling, General & Admin
4.135.555.25.694.194.734.178.730.0910.42
Upgrade
Research & Development
5.727.746.153.43.052.521.10.90.8221.5
Upgrade
Other Operating Expenses
00.0100000000
Upgrade
Operating Expenses
9.8613.2911.369.097.247.245.279.640.9231.92
Upgrade
Operating Income
-9.86-13.29-11.36-9.09-7.24-7.24-5.27-9.64-0.92-30.91
Upgrade
Interest Expense / Income
00000.10.0200.0301.3
Upgrade
Other Expense / Income
0.88-0.12-0.040.08-0.1-2.32-0.010.54
Upgrade
Pretax Income
-10.74-13.17-11.31-9.17-7.25-7.26-7.59-9.66-0.92-32.74
Upgrade
Net Income
-10.74-13.17-11.31-9.17-7.25-7.26-7.59-9.66-0.92-32.74
Upgrade
Shares Outstanding (Basic)
10777432100
Upgrade
Shares Outstanding (Diluted)
10777432100
Upgrade
Shares Change
40.49%2.14%-0.14%66.80%46.93%33.29%126.24%1528.42%55.50%41.89%
Upgrade
EPS (Basic)
-1.05-1.81-1.59-1.29-1.70-2.41-2.76-5.94-0.60-858.60
Upgrade
EPS (Diluted)
-1.05-1.81-1.59-1.29-1.70-2.41-2.76-5.94-0.60-858.60
Upgrade
Free Cash Flow
-8.57-11.63-9.42-7.34-6.41-5.53-4.91-0.81-0.77-28.25
Upgrade
Free Cash Flow Per Share
-0.84-1.60-1.33-1.03-1.50-1.91-2.25-0.84-12.97-742.86
Upgrade
Gross Margin
---------100.00%
Upgrade
Operating Margin
----------3053.20%
Upgrade
Profit Margin
----------3234.05%
Upgrade
Free Cash Flow Margin
----------2790.71%
Upgrade
EBITDA
-10.63-13.07-11.24-9.1-7.06-7.19-7.57-9.63-0.9-30.14
Upgrade
EBITDA Margin
----------2976.98%
Upgrade
Depreciation & Amortization
0.110.10.080.070.080.050.020.010.021.31
Upgrade
EBIT
-10.74-13.17-11.31-9.17-7.14-7.24-7.59-9.64-0.92-31.45
Upgrade
EBIT Margin
----------3106.10%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).